![Ken Cunningham Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Cunningham Cunningham
Président chez
Medherant Ltd.
Profil
Kenneth Thomas Cunningham currently works at Medherant Ltd., as Non-Executive Chairman from 2017, Xention Pharma Ltd., as Non-Executive Director, Sunergos Innovations Ltd., as Non-Executive Director, Abzena Holdings Us LLC, as Non-Executive Director from 2021, and The Royal College of Physicians, as Member.
Dr. Cunningham also formerly worked at Sosei R&D Ltd., as Chief Executive Officer from 2001 to 2005, Prosonix Ltd., as Non-Executive Chairman, PolyTherics Ltd., as Executive Chairman, Abzena Ltd., as Non-Executive Chairman from 2010 to 2018, SkyePharma Plc, as Director in 2010, Glaxo Wellcome Plc, as Medical Director, Xention Ltd., as Director from 2005 to 2016, Verona Pharma Plc, as Independent Non-Executive Director from 2015 to 2025, ALZA Corp., as Vice President-European Affairs, SEQUUS Pharmaceuticals, Inc., as Vice President-Clinical Development, and Warner Lambert (UK) Ltd., as Principal.
Dr. Cunningham received his doctorate degree from Imperial College London.
Postes actifs de Ken Cunningham Cunningham
| Sociétés | Poste | Début |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Directeur/Membre du Conseil | - |
Medherant Ltd.
 Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Président | 06/02/2017 |
Sunergos Innovations Ltd. | Directeur/Membre du Conseil | - |
Abzena Holdings Us LLC | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Ken Cunningham Cunningham
| Sociétés | Poste | Fin |
|---|---|---|
| VERONA PHARMA PLC | Directeur/Membre du Conseil | 07/10/2025 |
| ABZENA PLC | Président | 01/10/2018 |
Xention Ltd.
 Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Directeur/Membre du Conseil | 30/06/2016 |
| SKYEPHARMA PLC | Directeur Général | 30/09/2010 |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ken Cunningham Cunningham
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases | Health Technology |
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
Warner Lambert (UK) Ltd.
 Warner Lambert (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufacturer and wholesaler of pharmaceuticals and over the counter medicines | Health Technology |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosonix Ltd.
 Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Develops a portfolio of inhaled respiratory medicines | Health Technology |
PolyTherics Ltd.
 PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology Develops biomedical polymers for therapeutic applications | Health Technology |
Xention Ltd.
Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Health Technology |
Sunergos Innovations Ltd. | |
Abzena Holdings Us LLC |
